SHANGHAI CANCER INSTITUTE;CARSGEN THERAPEUTICS CO., LTD.
发明人:
Peng WANG,Hua JIANG,Linlin YANG,Zhimin SHI,Huamao WANG,Zonghai LI
申请号：
US16316331
公开号：
US20190233511A1
申请日:
2017.07.10
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Provided in the present invention is an antibody for anti-claudin 18A2 and an immune effector cell targeting claudin 18A2. Also provided are methods for inducing cell death and treating tumours.
